<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Antihypertensive dose response to thiazide therapy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Antihypertensive dose response to thiazide therapy</h1>
<div class="graphic"><div class="figure"><div class="ttl">Antihypertensive dose response to thiazide therapy</div><div class="cntnt"><img src="data:png;base64,iVBORw0KGgoAAAANSUhEUgAAAZoAAAD0CAMAAACVURDPAAAACXBIWXMAAAPoAAAD6AG1e1JrAAAAWlBMVEX///+1tbV/mczw7++IiIhJSUn/QEAAAAAAM5n/AAA/ZbL/vLx3d3cREREzMzO9yuX/f3/MzMz/Fxf/29va3eUiIiL/YmKZmZn/nZ1mZmZae72ZrdclUKjv8vlSeC5cAAAJ30lEQVR42u2dC5uyKhRGMUQyxdI0s8v//5tnb7DbZKl9UzKddz3TXAq0Ybm5KKQQAAAAAAAAAAAAAAAAAAAAAADwnWShEGWmtZIiMLrKUSKeEGhNatJMlKYWJuTfgC8oUlNXtTR5rilwND2lHSgbD9SUWWOU1RLo8vQC1PigRqX8OEcN1HikJhMyS3+0NVAzeTdAV909NKjxFqiBGgA1UAOgBmoA1ACogRoANVADvPCC6zWIGgA1UAOmUTM/geKBGgA1UAPerWY2Wy5LlJGfahaLw3x+WCxms/1y+WQzCLRpKrTlcjmb7a4lHaHGt7amdJIW9BpLutR3UONPN+BG0m4GNT6eDTgul3uoeR1eXyOCjE80v2X25lnNfLdHn24Ebn1NqRv+4y1zns9myv3uAD1j4OnoqeLf3rO+5qZCg56xapTROivfs77mrq0hPajchquhR9Z8cH0N6zlAzwA1YSbFx9fXQE9vN0BX5Gei9TXlbEF67k8hgDePa4axZD0z6PFQzZ2ezwxS//JQ+NNzA5azA+t5pdBeKWaoGcWR9SygxkM1Tg/UeKrmqtAWV+xmV+yXVxw7ivl4nWB/nXV32uBfvmA7vZr+8r0p42v6rd5csOVLgbuey7VQM1E3oCT59nItXwh8EEajdrOYQc3vtjVHvhD4IIzusiwp3WLfLYR+my+h5h3dgI4wusvCIma7h2q+L2r8Gj5ehdG9mgV/38+PYrY48st7fsxIZ9lGze733xTW13SE0f31jZ21cNjT13J+dLFSzkuxWzg1s0P5P4+aKYOTLMwW+wPVbNTZYyH8+/Lg1Ox2AmomUcNdAFJznLuGheIFUeOJGp4uRBUa/TwKru521O7ctjWLtzSAUDO4t/HO3hjU/Av7+RFqANRADYAaqAFQAzUAakAHdn2NKCsl8OnoUxDUAdH1gl1fI2SmlcA9BSZAugUznbcN4unoImsaJXD/mknUpGmqlQ2QLjVKiQb3r5mmPqN4oEYlS7vVlDZIFO5fM4maJghN+kgN06CtmQZFUWFyE3Z1A3h9jVODHtoUhGlYColxDYacYHDIWAKo8W/A78YpKdT4GDVaIWq8HXOirfHTDKmREmrQ1gCo+YoKjUGF5mUfLSNCqPGPABWav2rqkRUaLqV9iqYJgqBE1HjYDchQoXlboSmc3vQ0akw9PhPUfISqQufZ06hB59nv0wGo0L4FqPkIOFHjb+cZbY23amq0NZ6CEzXedtBwosbfCu3xiRruHeSkrsHE2kmi5uGJGrf0qU5FrnNMR5+CJydq2pUCUudY+jRF1DzpPLdqVIqlT9O4eXyiRrm1nM3VDbmgxg9YTeDaIrQ1vp0nqETD9V2DHtpfAWqgBkAN1ACogRoANQBqoAZADdQAL7zgeg2iBkAN1IDJ1GyjaIPC8VDNuoiZNYrHOzXOTByjeHxTs23NxKjTfFMTndQUqNJ8VRMXcRGttolEOXkXNUIkySqKSNBmlSCEfGxr1slqExVxFK2SBGXmQw/tR5zIZOtCqKuOw0joM+MaZ2bbncWGUBzf1HEYCb2MXUCgBq+vWUdFET0v53Wybeu4bYKR0Mu49TVhJUsT/PKcZ1fHxRgJvYy9f03KP9+yvubSp0M/7iU1/Gjesr7mEjcRhkL/HjVvUVMIDIVeUPOWtubRSMiboZDnnfr21kLqfSugH4yEng+FPlBsf7lT/0tqno+EOodCHym2v9yp/60L0ANGQj+GQp8otj99eWOCuQFtHVd8oNhuuidQMzjMzsW2oiga1pkb1Titk6S4dOo3b9qLEHHyZWquxkIraogiLsUoelqC/Y0T2UhWKwpK3njhNtoOhbcv72XDeZKfCi5/xUkSf6ma4tKdOxVsYQs2oj/oKfm0TX+Qaf2wrRm9l82G9awfxsr3RU1PE/0zAKLV5pyBXhoYBI869UP2cq1GbFakgPuhkeSqeMPJ1iv6c+2ixj75LWp6i+22BLerq4bjZKP3eO3p1D/bS3GjZhW56FjH1IlpY2VNb30TOTWb6IuiZlyxvdrdGtKp79nLVdTwi9v1Jo62rGbLF+gLp6bYfpOascX2mZ5wtxpua+KEQkPaQ2lFQrZfHDV+jh/v92J7aGvbEyvigio0G+qb97Y1f2x9zYjGyfu9fFfUjG6cfN7Ll6kZ36Z7vJcvU/P/AmqgBkAN1ACogRoANQBqoAZADdSAz1NmWiuJD673kDQTpalxuwcPqatamrtbC4GxvKVCa4z6hVsLIcuvY5c+pf++9AlZfl9NJmSW/ntbgyze9tCQxdtxDbJAzf9cDQAAADAlKnwpyYBsYKgCrXVWdpaxDp5lCl9Vc7qJeG20roWoaFuqL0+bln/jM1nB4H9vZPL23YVUJtN/0I5qhDRjy5gyBTp/SY37DDAmrUVoSE094F22abmsq1H/3sjk7t3lOhdZ6oOa0uT2RsS1SOl7zicOGhc1gc40vRhUp2P2kkmYmpLQC1XOB5nOXSJlM/Mm0gH1YGBs1HRF7X2pmXMYjKg0RyZvP9Ano4fyo0Kz5d5krgpzslo1Af9p6lPBXNTUunRlXKW5zeYSKcXHHH83Qa+asrJpZDagGNq0rrjzUYEzKrlVo/jzlnyIGjrqZWj4Q4bCSjeSK39dt2rIWFPaKxXlD58UIaHkYGtspdEm4v9M11xJqbpPTW7aJAOO0HNaOyYPRv2Lo5L7FDWsxvCBn9rjhOqp5twNcGqEqTsycZJaS5E156hx2QISxLHzNGqqkI4DPpoDJWXWW+W4tJyLjNdmeBM9Mrl7d760NfyZXDX/qCppuGfCDYU9/M9quBmputRw0qq5tDVV23d70ta0nwFW2XaKYq89Jd6DS2uFam3q4f/eyOTtu/OjhwYAAAAAAAAAAAAAAAAAAAAAAGAojbaTXbIHU17CHxexa61DY55t0GhcNu6BJwto1Te7LGhnbQ5VYyp6dKtpNwE1A9SkIjCV7FOTjlEjdfZQDaJmjBqR6tBOBw2FtPNs+Hs7z88+nfPkRKdG8XSZXHGkBTrLeDoL1V5Gp1IbpaXbiqHvktSQyVwbG5lVIO30N9p0Tg9Daq72Ah6poW/8U+kg5Zsb8i+lmzPVPh1eooaLvDKy1g3Xcoq9VZzMlnybPG+jplVjt6PsdkN65Mrak5e9gGdRo3jmoU7zikIgN+4Ad5L46Ss1VKi5fTljNZSTf1g15pz8h5pAuahreCukxm1FXvYCnrU17fFuq7BGnae030dNQAd6Zcq2b2DVZGc1d1ETsBrjnjlFZM77sVFTo/x7e2jSNiomtFM6VWlbHHNqa0woLmrseoPcJmvVcJKsVdMmP6kJKJVra6hRcrFGWfOy0lnb1mgDBQAAAAAAAAAAAAAAAAAAAAB4yH+I+7NJy2OpLQAAAABJRU5ErkJggg=="/></div><div class="graphic_lgnd">Antihypertensive response to bendrofluazide in relation to daily dose (in mg; multiply by 10 to get approximate equivalent doses of hydrochlorothiazide). The initial dose of 1.25 mg/day lowers the blood pressure in comparisonÂ with placebo; however, higher doses produced little further antihypertensive response. Each treatment group contained approximately 52 patients.</div><div class="graphic_reference">Data from: Carlsen JE, Kober L, Torp-Pedersen C, Johannsen P. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ 1990; 300:975.</div><div id="graphicVersion">Graphic 61248 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
